PainChek General Discussion, page-6833

First 6833 Last

Share
Profile

Follow
sabine

18,569 Posts.

3884

25/10/19

10:26

Post #: 41063077
Share

Originally posted by fattchoi ↑

My thought of the day

Much as having PCS, and any other partners, is a great advantage to PCK in terms of getting our product out there in the market, our partners will also gain greatly from having Painchek in their suite of products. It is a monopoly. It is a necessary tool. Therefore any partner of PCK will also enjoy that monopoly power.

Going by the testimonials that I posted recently from both professionals and real-life users, one can see Painchek is an efficient and reliable tool. It also boosts confidence and morale of carers. With no churn rate, one can safely conclude that it very quickly become a necessary tool in any aged care facility that have used it. In view of that, in time to come, as I said many times before, it would be partners courting PCK because any of those lacking Painchek in their arsenal is going to be at a disadvantage in their marketing pitch. Pain, after all, is an inevitable part of life and nobody will want to see their loved ones in pain for any longer than necessary.

I don't know if there is any lifespan in the contract between PCK and PCS or Procura, etc. If there is an end date, I dare bet it will be them courting PCK to renew their contracts in order that they can keep Painchek in their suite of products. Losing Painchek will be like losing an arm and will put those partners in great pain Likewise for all those aged care facilites that have renewed their contracts. Once one have been Paincheked, one can't live without it

So in conclusion, one can safely say with PCK, quarterly after quarterly, we are going to see growth of revenues. The revenue will NOT fluctuate like in many other businesses. And once we hit that profitable line and dividend is announced, we can only look forward to ever growing dividend.

How good is that?!

Expand

Another potential ‘ok’ allegiance may be with a drug manufacturer ?

https://www.mbaskool.com/fun-corner...cal-companies-in-world-2016.html?limitstart=0

The Top Pharma Companies in the World (2016) are :

1st Place : Johnson & Johnson

2nd Place : Roche

3rd Place : Novartis

4th Place : Pfizer

5th Place : Merck

6th Place : Sanofi

7th Place : GlaxoSmithKline

8th Place : Gilead

9th Place : Bayer

10th Place : AstraZeneca

Number 7 - GlaxoSmithKline 7 makes Panadol.
It has a market cap of more than US$100 billion on the New York Stock Exchange.
It’s website says it is in the business of manufacturing innovative healthcare products;

“We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.....
“Our goal is to be one of the world’s most innovative, best performing and trusted healthcare companies.
https://www.gsk.com/en-gb/about-us/

Imagine what exclusive rights would mean for any company which produces pain medication.

Cheers

Last edited by sabine: 25/10/19

PCK Price at posting: 32.0¢ Sentiment: Buy Disclosure: Held
13 Upvote

0 Great analysis

Reply

Top Stories

EMR

Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau

EBR

EBR reaches review milestone for wireless cardiac pacing device

TLG

Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year

HYT

Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep

I88

Infini rolls on with soil sampling at Portland Creek not long after making possible 'uranium history'

There are more pages in this discussion • 13,580 more messages in this thread...

First 6833 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.6¢		Change -0.002(5.26%)		Mkt cap ! $58.88M

Open	High	Low	Value	Volume
3.8¢	3.8¢	3.6¢	$38.06K	1.040M

Buyers (Bids)

No.	Vol.	Price($)
4	283684	3.6¢

Sellers (Offers)

Price($)	Vol.	No.
3.8¢	440	1

View Market Depth

No.	Vol.	Price($)
4	283684	0.036
4	375628	0.035
2	200000	0.034
3	890909	0.033
3	405933	0.032

Price($)	Vol.	No.
0.038	440	1
0.039	246044	4
0.040	121750	1
0.042	455579	3
0.043	403809	3

Last trade - 12.50pm 29/08/2024 (20 minute delay)

PCK (ASX) Chart

PainChek General Discussion, page-6833

Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau

EBR reaches review milestone for wireless cardiac pacing device

Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year

Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep

Infini rolls on with soil sampling at Portland Creek not long after making possible 'uranium history'

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PainChek General Discussion, page-6833

Top Stories

Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau

EBR reaches review milestone for wireless cardiac pacing device

Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year

Twiggy Forrest to acquire 40% of native hydrogen explorer – not long after putting Fortescue Future Industries to sleep

Infini rolls on with soil sampling at Portland Creek not long after making possible 'uranium history'

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News